Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +5.88%·Rev n/aQ2 22EPS +14.29%·Rev n/aQ1 22EPS +24.14%·Rev n/aQ4 21EPS +12.31%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Richard Eisenstadt — Chief Financial Officer

Vipin Garg — Chief Executive Officer

Scott Harris — Role not explicitly stated, likely a senior executive or medical/scientific officer

+9.2%1d on move date+3.7% vs SPY3d+9.3%5d−1.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access